BetterLife Pharma, Inc. is a biotechnology company, which engages in the business of developing compounds for the treatment of mental disorders. The firm is also involved in refining and development of drug candidates from a set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.